Financial News Feed

Weaker Buy Today AERI ranks #1116 as BUY CANDIDATE. Stronger Buy
Today AERI ranks #1116 as BUY CANDIDATE.

AERI stock Aerie Pharmaceuticals

AERI stock
Aerie Pharmaceuticals

Wall Street brokerages forecast that Aerie Pharmaceuticals Inc (NASDAQ:AERI) will post sales of $16.64 million for the current fiscal quarter, according to Zacks. Four analysts have issued estimates f...

Read more

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) closed at $46.82 after the last trading day, drawing interest from investors and traders. The stock trades on NSDQ in the Medical sector and Medical – Drugs...

Read more

We are contrasting Aerie Pharmaceuticals Inc. (NASDAQ:AERI) and its peers on their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. They are Dr...

Read more

Aerie Pharmaceuticals Inc (AERI) investors sentiment decreased to 1.1 in Q4 2018. It’s down -0.47, from 1.57 in 2018Q3. The ratio has dropped, as 77 investment professionals opened new and increased...

Read more

In reviewing some key ratios and quant data for Aerie Pharmaceuticals, Inc. (NasdaqGM:AERI), we note that the mother of all ratios (Return on Equity) stands at -1.020908 for the firm. ROE reveals what...

Read more

Analysts expect Texas Instruments Incorporated (NASDAQ:TXN) to report $1.13 EPS on April, 23.They anticipate $0.08 EPS change or 6.61% from last quarter's Daruma Capital Management Llc increased Aerie...

Read more

Aerie Pharmaceutical (AERI) are under the spotlight as the Chikou span line has crossed above the Tenkan line. The Ichimoku signals, indeed all Ichimoku elements, should never be taken in isolation, b...

Read more

Shares of Aerie Pharmaceutical (AERI) have seen the Mesa Adaptive Moving Average (MAMA) climb above the Fractional Moving Average or FAMA. The crossing of the MAMA and FAMA lines can be used to genera...

Read more

Analysts on the sell-side are offering a consensus “Buy” rating on shares of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Se...

Read more

Investors may be studying some short-term indicators on shares of Aerie Pharmaceutical (AERI). The current 7-day average directional indicator is Buy. This signal may be used to determine the market t...

Read more

In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics. First off we’ll take a look at the Price to Cash Flow ratio of Aerie Pharmaceuticals, In...

Read more

After looking for stocks with higher betas, we can see that Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has a current beta of 0.97. The beta of a stock is typically used as a historical volatility indic...

Read more

The stock of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) is a huge mover today! The stock decreased 2.82% or $1.32 during the last trading session, reaching Caesars Entertainment Corporation (NASDAQ:CZR...

Read more

Big Money Sentiment decreased to 1.1 in Q4 2018. It has change of 0.47, from 2018Q3's 1.57. The ratio is negative due to Aerie Pharmaceuticals, Inc....

Read more

Spectrum Asset Management Inc Nb decreased Fluor Corporation New (FLR) stake by 75.69% reported in 2018Q4 SEC filing. Spectrum Asset Management Inc Nb sold 21,800 shares as Fluor Corporation New (FLR)...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank